Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21032 | 375 | 36.9 | 86% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PDE 5 INHIBITION | Author keyword | 4 | 67% | 1% | 4 |
| 2 | PDE5 | Author keyword | 4 | 17% | 6% | 23 |
| 3 | PHOSPHODIESTERASE 5 | Author keyword | 3 | 16% | 5% | 19 |
| 4 | OSU 03012 | Author keyword | 3 | 50% | 1% | 4 |
| 5 | PHOSPHODIESTERASE 5 INHIBITION | Author keyword | 2 | 50% | 1% | 3 |
| 6 | PHOSPHODIESTERASE 5A | Author keyword | 1 | 38% | 1% | 3 |
| 7 | AMINOPYRAZINONE | Author keyword | 1 | 100% | 1% | 2 |
| 8 | BEIJING YOU YI HOSP | Address | 1 | 100% | 1% | 2 |
| 9 | EXPT RENAL P ERVAT UNIT | Address | 1 | 100% | 1% | 2 |
| 10 | PYRIDO1 2 EPURIN 43H ONE | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PDE 5 INHIBITION | 4 | 67% | 1% | 4 | Search PDE+5+INHIBITION | Search PDE+5+INHIBITION |
| 2 | PDE5 | 4 | 17% | 6% | 23 | Search PDE5 | Search PDE5 |
| 3 | PHOSPHODIESTERASE 5 | 3 | 16% | 5% | 19 | Search PHOSPHODIESTERASE+5 | Search PHOSPHODIESTERASE+5 |
| 4 | OSU 03012 | 3 | 50% | 1% | 4 | Search OSU+03012 | Search OSU+03012 |
| 5 | PHOSPHODIESTERASE 5 INHIBITION | 2 | 50% | 1% | 3 | Search PHOSPHODIESTERASE+5+INHIBITION | Search PHOSPHODIESTERASE+5+INHIBITION |
| 6 | PHOSPHODIESTERASE 5A | 1 | 38% | 1% | 3 | Search PHOSPHODIESTERASE+5A | Search PHOSPHODIESTERASE+5A |
| 7 | AMINOPYRAZINONE | 1 | 100% | 1% | 2 | Search AMINOPYRAZINONE | Search AMINOPYRAZINONE |
| 8 | PYRIDO1 2 EPURIN 43H ONE | 1 | 100% | 1% | 2 | Search PYRIDO1+2+EPURIN+43H+ONE | Search PYRIDO1+2+EPURIN+43H+ONE |
| 9 | PDE6 | 1 | 19% | 2% | 6 | Search PDE6 | Search PDE6 |
| 10 | PDE11 | 1 | 33% | 1% | 3 | Search PDE11 | Search PDE11 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHOSPHODIESTERASE 5 INHIBITION | 7 | 24% | 7% | 25 |
| 2 | PDE5 INHIBITORS ENHANCE | 6 | 100% | 1% | 4 |
| 3 | DEPENDENT INCREASES | 4 | 67% | 1% | 4 |
| 4 | SELECTIVE PDE5 INHIBITORS | 4 | 46% | 2% | 6 |
| 5 | PHOSPHODIESTERASE 5 | 2 | 16% | 4% | 14 |
| 6 | KINASE 1 INHIBITOR | 2 | 44% | 1% | 4 |
| 7 | UK 343 664 | 2 | 67% | 1% | 2 |
| 8 | PHOSPHODIESTERASE 5 INHIBITORS | 2 | 14% | 3% | 13 |
| 9 | 2 5 ANHYDRO 3 4 6 TRI O BENZOYL D ALLONIC ACID | 1 | 50% | 1% | 2 |
| 10 | CARDIOMYOCYTE RESTRICTED INACTIVATION | 1 | 50% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cardiac Uses of Phosphodiesterase-5 Inhibitors | 2012 | 31 | 49 | 37% |
| Cyclic Guanosine Monophosphate Signaling and Phosphodiesterase-5 Inhibitors in Cardioprotection | 2012 | 17 | 64 | 41% |
| PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer | 2015 | 1 | 133 | 35% |
| Phosphodiesterases and cardiac cGMP: evolving roles and controversies | 2011 | 21 | 58 | 40% |
| Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases | 2011 | 16 | 69 | 39% |
| Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond | 2014 | 4 | 92 | 28% |
| Cyclic GMP-Dependent Signaling in Cardiac Myocytes | 2012 | 16 | 75 | 27% |
| Novel phosphodiesterase type 5 modulators: a patent survey (2008-2010) | 2011 | 11 | 19 | 37% |
| Phosphodiesterase 5 inhibitors: are they cardioprotective? | 2009 | 13 | 64 | 36% |
| Phosphodiesterase-5 inhibitors for male erectile dysfunction | 2003 | 7 | 27 | 56% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BEIJING YOU YI HOSP | 1 | 100% | 0.5% | 2 |
| 2 | EXPT RENAL P ERVAT UNIT | 1 | 100% | 0.5% | 2 |
| 3 | PAULEY HEART | 1 | 12% | 2.7% | 10 |
| 4 | METAB CARDIOVASC DRUG DISCOVERY | 1 | 19% | 1.1% | 4 |
| 5 | COMPARAT MED COMPARAT PATHOL | 1 | 33% | 0.5% | 2 |
| 6 | FOR ERGRP 923 | 1 | 21% | 0.8% | 3 |
| 7 | ARTIFICIAL CIRCULATORY | 1 | 50% | 0.3% | 1 |
| 8 | CARDIOLKECK MED | 1 | 50% | 0.3% | 1 |
| 9 | IND COOPERAT PROJECTCHIKUSA KU | 1 | 50% | 0.3% | 1 |
| 10 | NEUROENDOCRINOL NEUROGENESIS GRP | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000160028 | ERECTILE DYSFUNCTION//INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH//VARDENAFIL |
| 2 | 0.0000155537 | ROLIPRAM//PDE4//PHOSPHODIESTERASE |
| 3 | 0.0000151243 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
| 4 | 0.0000116120 | ATP ASE ACTIVITY//AMARANTHUS CAUDATHUS//MAIZE CELLS |
| 5 | 0.0000096681 | SILDENAFIL ANALOGUE//TADALAFIL ANALOGUE//HOMOSILDENAFIL |
| 6 | 0.0000094583 | YC 1//BAY 41 2272//SOLUBLE GUANYLYL CYCLASE |
| 7 | 0.0000091686 | CORPUS CAVERNOSUM//ERECTILE DYSFUNCTION//HUMAN CORPUS CAVERNOSUM |
| 8 | 0.0000078178 | SECT CLIN MOL PSYCHOBIOL//NEURONAL NITRIC OXIDE SYNTHASE NOS1//PSYCHOSOCIAL GENOMICS |
| 9 | 0.0000074674 | SECC INSUFICIENCIA CARDIACA TRASPLANTE CARDIACO//SERV CARDIOL ADULTOS//LEFT HEART DISEASE |
| 10 | 0.0000074165 | CHINESE PEDIAT//PHARMACOINFORMAT NANOTECHNOL//MED GENET PEDIAT MED |